Literature DB >> 20497930

Syndrome of inappropriate antidiuretic hormone associated with tolterodine therapy.

Monique K Bryan1, May T Nguyen, Olga Hilas.   

Abstract

OBJECTIVE: To present a case of syndrome of inappropriate antidiuretic hormone (SIADH) associated with the use of tolterodine.
SETTING: An acute-care unit at a university hospital with a comprehensive program for elders. CASE
SUMMARY: In this case report, we present a 99-year-old female who was admitted to our unit for suspected gastrointestinal bleeding who subsequently developed hyponatremia. After the initiation of tolterodine for urinary incontinence, the patient's sodium dropped to 121 mEq/L (from a usual baseline that ranged between 128 mEq/L and 134 mEq/L). Laboratory and urinary findings revealed a serum osmolality of 220 mOsm/kg, a urinary osmolality of 340 mOsm/kg, and a urinary sodium of 101 mmol/L, suggesting a euvolemic hyponatremic state consistent with SIADH. Tolterodine therapy was promptly discontinued, and patient sodium levels normalized.
CONCLUSION: Although the etiology of SIADH is often obscure and multifactorial, clinicians should be aware that it is a major cause of hyponatremia among hospitalized elderly patients, and drug therapies must always be evaluated to prevent further complications.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20497930     DOI: 10.4140/TCP.n.2010.320

Source DB:  PubMed          Journal:  Consult Pharm        ISSN: 0888-5109


  2 in total

1.  Recurrent hyponatremia due to tolterodine.

Authors:  Ihsan Ustun; Mürsel Davarcı; Onur Demirbaş; Nilgul Ustun; Cumali Gokce
Journal:  Can Urol Assoc J       Date:  2012-06       Impact factor: 1.862

Review 2.  Genomic Variation and Pharmacokinetics in Old Age: A Quantitative Review of Age- vs. Genotype-Related Differences.

Authors:  Christof M Dücker; Jürgen Brockmöller
Journal:  Clin Pharmacol Ther       Date:  2018-04-02       Impact factor: 6.875

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.